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PREVALENCE OF ECTOPIC 
THYMIC TISSUE IN 
MYASTHENIA GRAVIS AND 
ITS CLINICAL SIGNIFICANCE 
Forty patients with myasthenia gravis underwent maximal thymectomy. Complete 
histologic study findings were available for 38 patients. The prevalence of ectopic 
thymic tissue was 39.5% (15 of 38). On the basis of the presence or absence of ectopic 
thymic tissue, patients were divided into two groups: group I had ectopic thymic 
tissue and group II had no ectopic thymic tissue. Male/female ratio was almost equal 
(1.1:1) in group I, whereas in group II the ratio was 1:2.8. The duration of the disease 
was less than 1 year in 80% of group I and 47.8% of group II patients (p = 0.05). 
Furthermore, ectopic thymic tissue (group I) was associated with poor outcome of 
operation (p = 0.003). Only 2 (13.3%) of 15 patients in group I had complete 
remission as compared with 11 (47.8%) of 23 patients in group II. Thus it appears 
that the presence of ectopic thymic tissue not only modifies some of the clinical 
parameters of myasthenia gravis, but also could serve as a prognostic factor in 
predicting the outcome of operation. (J THORAC CARDIOVASC SURG 1995;109:632-5) 
M. Ashour, FRCS, Riyadh, Saudi Arabiü 
T here are ample data now to suggest that the thymus gland plays a major role in the pathogen- 
esis of myasthenia gravis (MG). a-3 Thymectomy is
increasingly being accepted as a treatment modality 
for MG. 4"8 However, thymectomy does not achieve 
complete remission rates consistently in all patients. 
In some of these cases, foci of thymic tissue have 
been left behind at various locations. 8' 9 Some of 
these ectopic locations are accessible through vari- 
ous approaches used for thyrnectomy. On the other 
hand, ectopic thymic tissue in the retrocarinal area 
is not accessible through even the most aggressive 
approach. 1° The significance of ectopic thymic tissue 
with regard to clinical characteristics of MG and 
outcome of operation, to my knowledge, has not 
been studied before. In this report I present the 
pattern of MG in patients with ectopic tissue and 
compare it with the pattern in those without ectopic 
thymic tissue. 
Patients and methods 
The cases of 40 patients with MG who were operated on 
consecutively between July 1987 and June 1993 at King 
Khalid University Hospital, Riyadh, Säudi Arabia, were 
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reviewed retrospectively. MG was diagnosed in the pa- 
tients on the basis of clinical presentation and edropho- 
nium chloride (Tensilon) test results. All were receiving 
anticholinesterase inhibitors. Fifteen patients were receiv- 
ing steroids and three were also receiving azathioprine. 
Most were having uncontrolled myasthenic symptoms 
with medical treatment. Any attempt to taper oft medica- 
tions resulted in increased isability. 
Before operation all patients had a mean of three 
sessions of plasmapheresis. This protocol was adopted 
with the aim of not only improving patient status before 
operation, but also decreasing the incidence of morbidity 
after operation. Patients underwent ranscervical-trans- 
sternal "maximal" thymectomy according to technique 
described by Jaretzki and Wolff) ~ During the first phase 
of operation via transcervical incision, upper poles of 
thymus were isolated carefully. A thorough search was 
made to locate any suspicious thymic rests in the retro- 
thyroid area and in the pretracheal dipose tissue. Most of 
the adipose tissue in these areas was carefully removed 
and sent for histologic examination i separate containers. 
The second phase of operation was done via the trans- 
sternal approach. All visible thymus gland was excised en 
bloc with anterior mediastinal adipose tissue. The left 
phrenic nerve was lifted oft the pericardium to facilitate 
gland dissection in the hilar region. Adipose tissues in the 
retro-innominate-vein area, aortocaval window, aortopul- 
monary window, and both cardiophrenic angles were seht 
separately for histopathologic examination. 
Multiple microscopic sections were taken from each 
specimen and stained with hematoxylin and eosin. These 
were examined for thymic tissues. Thymic tissue was 
identified by the presence of Hassall's corpuscles. If the 
identification of thymic tissues was in doubt, staining with 
T-cell markers and immunohistochemical st ining with 
cytokeratin were done for the identification of thymoeytes 
and epithial cells, respectively. On the first day after 
operation all patients were started on half the amount of 
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Table I. Age and sex distribution 
Male Female 
Age group (yr) patients patients Total Percent 
Up to 20 3 11 14 36.8 
21-40 8 12 20 52.6 
40+ 3 1 4 10.5 
Table II. Details of ectopic thymic tissue 
Patient No. of 
no. ectopic sites Site of ectopic thymic tissue 
1 1 Right cardiophrenic angle 
2 2 Left retrothyroid lobe and left cardiophrenic 
angle 
3 1 Retro-innominate vein 
4 1 Below thyroid isthmus 
5 1 Pretracheal tissue 
6 1 Left retrothyroid lobe 
7 1 Left carotid sheath 
8 1 Aortopulmonary window 
9 4 Right and left cardiophrenic angles, adja- 
cent to left thyroid lobe, and retro-in- 
nominate vein. 
10 1 Left retrothyroid lobe 
11 1 Adjacent to left thyroid lobe 
12 1 Left retrothyroid lobe 
13 1 Adjacent to left thyroid lobe 
14 1 Below thyroid isthmus 
15 1 Below thyroid isthrnus 
their preoperative medications. The outcome of operation 
was judged according to the following criteria: (1) eom- 
plete remission was achieved when the patient had no 
symptoms and received no drugs, (2) pharmacologic re- 
mission occurred when the patient had no symptoms with 
half or less of the amount of preoperative drugs, (3) 
improved condition occurred in patients who had no 
symptoms with the same preoperative drugs, and (4) no 
change occurred when the patient had symptoms with 
medical therapy. 
Statistical analysis was done by Mann-Whitney rank- 
sum test with use of BMDP statistical package version 
7.01, 1994 (University of California Press, Berkeley, Calif.). 
Results 
Complete histologic study findings were available 
for 38 of 40 patients. The two patients with incom- 
plete data shall not be considered further. There 
were 14 male and 24 female patients with ages 
ranging from 10 to 61 years and a mean age of 26.8 
years (Table I). Duration of disease ranged from 1 
month to 20 years with mean of 34.9 months. Fifteen 
patients (39.5%) had ectopic thymic tissue at 19 
locations (Table II). Ectopic locations were in the 
heck in 63.2% of cases (12 of 19) and in the 
cardiophrenic angles in 21% (4 of 19). Eight (57%) 
Table III. Ectopic and nonectopic group 
characteristics 
No. of patients 
Characteristics Group I Group II 
Sex 
Male 8 6 
Female 7 17 
Age 
Up to 20 yr 5 9 
21-40 yr 9 11 
40+ yr 1 3 
Duration of symptoms 
Up to 1 yr 12 11 
>1 yr 3 12 
Osserman class 
I 3 3 
II 7 8 
III 5 9 
IV 0 3 
Anti-acetylcholine receptor 
antibodies 
Positive 5 10 
Negative 3 10 
Not done 7 3 
Histologic type of thymus 
Hyperplasia 14 19 
Atrophic 1 4 
Outcome of thymectomy 
Complete remission 2 (13.3%) 11 (47.8%) 
Pharmacologlc remission 8 (53.3%) 12 (52.2%) 
Improved 5 (33.35%) 0 (0%) 
of 14 male patients and 7 (29.2%) of 24 female 
patients had ectopic thymic tissue. Fourteen 
(41.2%) of 34 patients with ectopic thymic tissue 
were younger than 40 years old as compared with 
only 1 of 5 patients older than 40 years. Fourteen 
(42.4%) of 33 patients with thymic hyperplasia had 
ectopic thymic tissue whereas only 1 of 5 with 
atrophic thymus had ectopic thymic tissue. 
On the basis of the presence or absence of ectopic 
thymic tissue, 38 patients were divided into two 
groups: group I patients had ectopic thymic tissue 
and group II patients had no ectopic thymic tissue. 
The various characteristics of the two groups are 
depicted in Table III. Male:female ratio was almost 
equal (1.1:1) in group I whereas in group II the ratio 
was 1:2.8. Of group I patients 80% (12 of 15) had 
duration of disease up to 1 year whereas in group II 
only 47.8% (11 of 23) had duration of disease up to 
1 year (p = 0.05). There was no significant difference 
in Osserman class in the two groups. 
The follow-up period ranged from 4 months to 6 
years with a mean of 14.5 months. All patients in 
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both groups benefited from thymectomy. However, 
the complete remission rate in group I was only 
13.3% (2 of 15) compared with 47.8% (11 of 23) in 
group II. All the remaining patients in group II 
achieved pharmacologic remission whereas in group 
I only 53.3% (8 of 15) achieved pharmacologic 
remission and 33.3% (5 of 15) had improved condi- 
tions (p = 0.003). 
Discussion 
Thymus gland develops as two separate lobes 
from the third pharyngeal pouch along with inferior 
parathyroid glands. During subsequent growth it 
descends into the anterior mediastinum toa variable 
extent and two lobes join at a variable distance for 
variable length. This complicated evelopment pro- 
vides ample scope for ectopic and abnormal position 
of thymus gland as was seen in two patients in this 
series in whom one lobe or the whole of the thymus 
was seen passing behind the left innominate vein. 
Jaretzki and Wolff la noted 98% of patients with MG 
had anatomic variability in the distribution of thymic 
tissue in the mediastinum. Goldstein and Mackay a2 
reported 20% of normal subjects had ectopic thymic 
tissue. 
In an autopsy study on subjects without myasthe- 
nia gravis, 44.4% had ectopie thymic tissue in ante- 
rior mediastinal fat and 7.4% had ectopic thymic 
tissue in the retrocarinal area. a° In patients with 
myasthenia gravis, 72.2% had ectopic thymic tissue 
in anterior mediastinal rat. ~3 In the present series, I
found ectopic thymic tissue in 39.5% of patients at 
variable locations (Table II). Twelve (63.2%) of 19 
ectopic sites were in the neck close to the thyroid 
gland. This is understandable b cause mbryologi- 
cally the development of thyroid and thymus glands 
is closely related. On several occasions, I have found 
one or both inferior parathyroid glands embedded 
in the substance of thymus gland near the upper 
poles. Four (21%) of 19 ectopic sites were in 
cardiophrenic angles. 
Although most patients had a single ectopic site, 
two patients had ectopic thymic tissue at multiple 
locations. One of these two had ectopic thymic 
tissue at four different locations. This raises the 
question of multiple ectopic sites in at least some 
patients at hitherto unknown sites. Ectopic thymic 
tissue was found in 57% of male patients and 29.2% 
of female patients. This indicates a relative prepon- 
derance of ectopic tissue in the male population. 
Ectopic thymic tissue was seen more frequently in 
patients younger than 40 years old compared with 
those older than 40 years (41.2% versus 25%). On 
the basis of the high prevalence of ectopic thymic 
tissue in the neck and cardiophrenic angles, I rec- 
ommend that dissection in these areas should form 
an integral part of operation for MG, particularly in 
male patients younger than age 40 years. 
The clinical characteristics of group I and group II 
patients are shown (Table II). Some of these were 
surprisingly different between groups. Male:female 
ratio was almost equal in group I whereas women 
outnumbered men by a factor of 2.8 in group II. The 
duration of disease was less than 1 year in 80% of 
group I patients and 47.8% of group II patients (p = 
0.05). In group I, the presence of ectopic thymic 
tissue not only modified some of the clinical pattern 
of MG, but also altered the outcome of operation. 
The complete remission rate was 13.3% in group I 
and 47.8% in group II. Furthermore, all the remain- 
ing patients in group II had pharmäcologic remis- 
sion whereas in group I, 53.3% (8 of 15) had 
pharmacologic remission and 33.3% (5 of 15) had 
improved conditions (p = 0.003). When the com- 
plete remission rate is taken as the only parameter 
to judge the outcome of operation, it is apparent 
that patients with ectopic thymic tissue had less 
favorable outcomes as compared with the outcomes 
of those without ectopic thymic tissue. The presence 
of ectopic thymic tissue, thus, could have prognostic 
value in determining the outcome of operation. 
Poor outcome of operation in these patients might 
be a result of still more ectopic sites that are 
inaccessible by the present radical techniques of 
thymectomy. 
In conclusion, it seems that the presence of 
ectopic thymic tissue altered some of the clinical 
parameters of MG and was also associated with 
poor outcome of operation. 
I thank Ms. Timmie M. Luces for typing this manu- 
script. 
REFERENCES 
1. Lennon VA, Lambert EH. Myasthenia gravis induced 
by monoclonal antibodies to acetylcholine r ceptors. 
Nature 1980;285:238-40. 
2. Wekerle H, Muller-Hermelink HK. The thymus in 
myasthenia gravis. Curr Top Pathol 1986;75:179-206. 
3. Lennon VA. The immunopathology of myasthenia 
gravis. Hum Pathol 1978;9:541-51. 
4. Keyness GL. The results of thymectomy in myasthe- 
nia gravis. BMJ 1949;2:611-6. 
5. Eaton LM, Clargett OT. Present status of thymec- 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 4 
Ashour 6 3 5 
tomy in the treatment of myasthenia gravis. Am J 
Med 1955;19:703-15. 
6. Papatestas AE, Genkins G, Morowitz SH, Kornfeld P. 
Thymectomy in myasthenia gravis: pathologic, linical 
and electrophysiological orrelation. Ann N Y Acad 
Sci 1976;274:555-73. 
7. Fischer JE, Grinvalski HT, Nussbaum MS, Sayers HJ, 
Cole RE, Samaha FJ. Aggressive surgical approach 
for drug-free remission from myasthenia gravis. Ann 
Surg 1987;45:496-503. 
8. Jaretzki A III, Penn AS, Younger DS, et al. "Maxi- 
mal" thymectomy for myasthenia gravis: results. J 
THORAC CAaDIOVASC StJR~ 1988;95:747-57. 
9. Rosenberg M, Jauregui WD, Herrera MR, Roncoroni 
AJ, Rojas OR, Olmedo GSM. Recurrence of thymic 
hyperplasia after transsternal thymectomy in myasthe- 
nia gravis. Chest 1986;89:888-9. 
10. Fukai I, Funato Y, Mizumo T, Hashimoto T, 
Masaoka A. Distribution of thymic tissue in the 
mediastinal adipose tissue. J THORaC CagDIOVASC 
SURG 1991;101:1099-102. 
11. Jaretzki A III, Wolff M. "Maximal" thymectomy for 
MG: surgical anatomy and operative technique. J 
TnORAC CARDIOVASC SURG 1988;96:711-6. 
12. Goldstein G, Mackay I. The human thymus. London: 
Heinemann Medical Books, 1969:165-254. 
13. Masaoka A, Nagaoka Y, Kotabe Y. Distribution of 
thymic tissue at the anterior mediastinum: current 
procedure in thymectomy. J THOP, AC CARDIOVASC 
SURG 1975;70:747-54. 
1-800-55-MOSBY 
This number links you to the full text of articles published inover 25,000 journals, including all Mosby journals. MOSBYDocument 
Express TM, a rapid response information retrieval service, provides quick turnaround, 24-hour availability, and speedy delivery 
methods. For inquiries and pricing information, call our toll-free, 24-hour order line: 1-800-55-MOSBY; outside the United States: 
415-259-5046; fax: 415-259-5019; E-mail: mosbyexp@class.org. 
MOSBY Document Express TM is offered in cooperation with Dynamic Information Corp. 
